News & Analysis on Clinical Trial Services & Contract Research And Development
Celadon Pharmaceuticals announced today (November 16) that it has secured a new sales contract with an unnamed European medical cannabis company.
A step forward has been taken toward a cure for a common and distressing skin condition after Novartis announced positive data from a clinical trial.
Oxford Cannabinoid Technologies Holdings plc (OCTP), the pharmaceutical company developing prescription cannabinoid medicines, has announced that all cohorts have been dosed in a phase 1 study of OCT461201.
The first and only enzyme replacement therapy for the treatment of a very rare and complex blood disorder has been approved by the US Food and Drug Administration.
The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project...